Search

everythinglearnresearchcommunity

for

Search:↓

A man developed a skin reaction from metronidazole, which improved after stopping the drug and starting steroids.

Cyclosporine A can reduce inflammation in dogs with sebaceous adenitis, but ongoing treatment is needed.

Hidradenitis suppurativa is a skin disease caused by the breakdown of the skin's natural immune barriers, especially around hair follicles.

A young tapir with a rare skin condition improved after treatment with wound cleaning, cream, and oral medication.

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

IL-1 family cytokines are crucial for skin defense and healing, but their imbalance can cause skin diseases.

Erdr1 could be a new marker for diagnosing hair loss.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

The project created a standardized system for classifying skin lesions in lab rats and mice.

Enzymes called PADIs play a key role in hair growth and loss.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

MALDI Imaging Mass Spectrometry is a useful method for studying skin conditions, but sample preparation is crucial for accurate results.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

The document is a detailed medical reference on skin and genetic disorders.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

A chemical called 5-Bromo-2′-deoxyuridine caused rapid hair loss in mice by killing certain skin cells through a specific cell death pathway.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

The symposium concluded that a specific lipid might cause hair loss, inflammation is a key factor, and stem cells in bald scalps aren't working right, suggesting new treatment targets.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.